
Samir Vasant Parikh MD FASN
Glomerular Disease, Hereditary Kidney Disease Genetics
Professor of Clinical Medicine, Nephrology at The Ohio State University
Join to view full profile
543 Taylor AveColumbus, OH 43203
Phone+1 614-293-4837
Fax+1 614-293-3125
Dr. Parikh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Samir Parikh is a nephrologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 11 years. He specializes in the glomerular diseases with a special focus in the management of lupus nephritis, thrombotic microangiopathy and monoclonal gammopathy. He is experienced in hypertension, general nephrology, acute renal failure, and chronic kidney disease management.
Education & Training
Ohio State University HospitalFellowship, Nephrology, 2009 - 2011
Ohio State University HospitalResidency, Internal Medicine, 2006 - 2009
University of Cincinnati College of MedicineClass of 2006
Certifications & Licensure
OH State Medical License 2006 - 2028
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- Spatial transcriptomic analysis of kidney biopsies identifies activation of complement and SPP1 networks ininfection-associated glomerulonephritis.Spyros Karaiskos, Luis Santana-Quintero, Cherri Bott, Rahul Paul, Sergey V Brodsky
Frontiers in Nephrology. 2026-01-01 - 7 citationsEffect of Long-Term Voclosporin Treatment on Renal Histology in Patients With Active Lupus Nephritis With Repeat Renal Biopsies.Brad H Rovin, Clarissa Cassol, Samir V Parikh, Amit Saxena, Neil Solomons
Arthritis & Rheumatology. 2025-10-01 - 7 citationsInhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related vascular thrombosis with microvascular injury and its consequences.Danyang Zhao, Chao Han, Elmina Mammadova-Bach, Kanako Watanabe-Kusunoki, Tamisa Seeko Bandeira Honda
Kidney International. 2024-11-01
Lectures
- Renal Biopsy: Clinical Correlations 2019American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
Other
- Differential diagnosis and evaluation of glomerular diseaseParikh SV, Hebert LA
http://www.uptodate.com/contents/differential-diagnosis-and-evaluation-of-glomerular-disease
UpToDate, Wolters Kluwer Health - 2012-06-13
Press Mentions
Lupus Nephritis Drug Voclosporin Shows Efficacy, Safety over 3 YearsNovember 29th, 2022
Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus NephritisNovember 15th, 2021
Kezar Reports Third Quarter Financial Results and Provides Business UpdateNovember 9th, 2021
Professional Memberships
- Member
- Member
- Member
Other Languages
- Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









